Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer

Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer

Abstract Background Modified FOLFIRINOX and gemcitabine plus nab-paclitaxel (GEM-NAB) have been recommended as first-line therapies for advanced pancreatic cancer (PC). Due to the lack of evidence to directly compare them, we conducted this network meta-analysis to indirectly compare the effectivene...

Full description

Bibliographic Details
Main Authors: Jiayuan Chen, Qingling Hua, Haihong Wang, Dejun Zhang, Lei Zhao, Dandan Yu, Guoliang Pi, Tao Zhang, Zhenyu Lin
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Cancer
Subjects:
Pancreatic cancer
Modified FOLFIRINOX
Gemcitabine
Nab-paclitaxel
Network meta-analysis
Systematic review
Online Access:https://doi.org/10.1186/s12885-021-08605-x

Internet

https://doi.org/10.1186/s12885-021-08605-x

Similar Items